ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Top Stocks Set to Outperform
Over the Next 1 to 3 Months.
Click for your free picks >>

Quote:

Search for Ticker

Free Membership

Search:

ABCO: Advisory Board Co (the) - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

ADVISORY BOARD CO (THE) (NASD)
ABCO	25.01	0.16	(0.64%)	Vol. 120,032	16:00 ET

The Advisory Board Company provides best practices research and analysis to the health care industry, focusing on business strategy, operations and general management issues. The Company provides its best practices research and analysis through discrete annual programs to a membership of more than 2,000 hospitals, health systems, pharmaceutical and biotech companies, health care insurers, and medical device companies in the United States. Each program provides members with best practices research reports, executive education and other supporting research services.

General Information

ADVISORY BOARD

2445 M Street NW Washington, DC 20037 Phone: 202-266-5600 Fax: 202-672-5700 Web: www.advisoryboardcompany.com Email: jacobsg@advisory.com

Industry	BUSINESS SVCS
Sector:	Business Services

Fiscal Year End	March
Last Reported Quarter	09/30/09
Next EPS Date	02/08/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	24.85
52 Week High	28.80
52 Week Low	13.45
Beta	1.10
20 Day Moving Average	54,070.55
Target Price Consensus	23.5

% Price Change
4 Week	-1.94
12 Week	-6.60
YTD	11.12

% Price Change Relative to S&P 500
4 Week	-3.00
12 Week	-11.94
YTD	-8.03

Share Information
Shares Outstanding (millions)	15.52
Market Capitalization (millions)	384.64
Short Ratio	5.90
Last Split Date	N/A

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.29
Current Year EPS Consensus Estimate	1.11
Estimated Long-Term EPS Growth Rate	13.50
Next EPS Report Date	02/08/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	3.22
30 Days Ago	3.22
60 Days Ago	3.22
90 Days Ago	3.22

Fundamental Ratios

P/E
Current FY Estimate:	22.29
Trailing 12 Months:	21.55
PEG Ratio	1.65

EPS Growth
vs. Previous Year	-18.75%
vs. Previous Quarter	-3.70%

Sales Growth
vs. Previous Year	1.21%
vs. Previous Quarter:	2.86%

Price Ratios
Price/Book	3.71
Price/Cash Flow	13.35
Price / Sales	1.67

ROE
09/30/09	17.69
06/30/09	19.19
03/31/09	20.23

ROA
09/30/09	5.59
06/30/09	6.20
03/31/09	6.91

Current Ratio
09/30/09	0.93
06/30/09	0.83
03/31/09	0.81

Quick Ratio
09/30/09	-
06/30/09	0.83
03/31/09	0.81

Operating Margin
09/30/09	7.78
06/30/09	8.41
03/31/09	9.32

Net Margin
09/30/09	7.49
06/30/09	12.38
03/31/09	13.71

Pre-Tax Margin
09/30/09	7.49
06/30/09	12.38
03/31/09	13.71

Book Value
09/30/09	6.68
06/30/09	6.75
03/31/09	6.38

Inventory Turnover
09/30/09	-
06/30/09	-
03/31/09	-

Debt-to-Equity
09/30/09	-
06/30/09	0.00
03/31/09	0.00

Debt to Capital
09/30/09	-
06/30/09	0.00
03/31/09	0.00


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research